Neogen Chemicals Limited

NSE:NEOGEN.NS

2183.15 (INR) • At close September 19, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Revenue 1,799.51,996.51,644.41,617.11,648.82,039.21,862.51,481.21,4791,5681,326.41,131.8846.367926.961851.785819.504765.906822.992822.948770.859644.418798.272632.031572.934387.346
Cost of Revenue 1,1921,327909.8875.8918.51,222.11,057.3788.68171,627.2740.9641.5465.176942.176498.359479.72474.042835.963489.598471.765382.503574.996387.311329.01222.98
Gross Profit 607.5669.5734.6741.3730.3817.1805.2692.6662-59.2585.5490.3381.191-15.215353.426339.784291.864-12.971333.35299.094261.915223.276244.72243.924164.366
Gross Profit Ratio 0.3380.3350.4470.4580.4430.4010.4320.4680.448-0.0380.4410.4330.45-0.0160.4150.4150.381-0.0160.4050.3880.4060.280.3870.4260.424
Reseach & Development Expenses 0000056.60004700029.400020.4130001.9845.753.143.14
General & Administrative Expenses 00000303.5000293.1000163.7300041.6050002.81131.7724.69524.695
Selling & Marketing Expenses 0000059.400017.50006.300026.300025.05810.586.6056.605
SG&A 367.6370.2364.4306.1320.6362.9381.4331.1316.9310.6263.6203.479164.239170.0352.12554.33146.64867.90546.83946.56539.0427.86942.3531.331.3
Other Expenses 15.722.115.818.917.917.3144.29-0.90.31.50.342-1.1520.3480.340.479-0.9140.1840.4510.9070.2872.4471.6890.422
Operating Expenses 367.6370.2589.1540504.5534.1545.2488.9454.4-284.6384.6308.2243.457-181.79202.602202.238172.242-153.867186.923164.23155.99965.53149.542150.688102.552
Operating Income 239.9299.3162.2220.7243.9300.5273.8208.5207.6-292.4200.9184.3137.734166.575150.824137.546119.622140.896146.427134.864105.916157.74695.17893.23661.814
Operating Income Ratio 0.1330.150.0990.1360.1480.1470.1470.1410.14-0.1860.1510.1630.1630.180.1770.1680.1560.1710.1780.1750.1640.1980.1510.1630.16
Total Other Income Expenses Net -82.5-74.8-105.2-110.9-107.6-93.4-66.6-68.6-51.596.5-63.4-40.8-35.44-34.21-31.406-34.936-31.856-27.792-31.938-25.812-30.98-35.693-27.375-27.523-25.043
Income Before Tax 157.4224.557109.8136.3207.1207.2139.9156.1186.8137.5143.5102.294132.365119.418102.6187.766113.104114.489109.05274.936122.05367.80365.71336.771
Income Before Tax Ratio 0.0870.1120.0350.0680.0830.1020.1110.0940.1060.1190.1040.1270.1210.1430.140.1250.1150.1370.1390.1410.1160.1530.1070.1150.095
Income Tax Expense 42.955.446.430.638.863.960.341.245.13132.931.728.73539.13434.29528.82226.59339.22333.13432.02220.02434.79424.64515.4848.15
Net Income 114.7169.310.679.297.5143.2146.998.7111156.4104.6111.773.693.23185.173.78861.17373.06981.91877.0354.54787.25943.35750.22928.621
Net Income Ratio 0.0640.0850.0060.0490.0590.070.0790.0670.0750.10.0790.0990.0870.1010.10.090.080.0890.10.10.0850.1090.0690.0880.074
EPS 4.356.420.413.183.915.745.893.964.455.254.494.793.1543.653.162.623.133.513.32.343.742.162.451.43
EPS Diluted 4.356.420.413.183.915.745.893.954.455.254.494.793.1543.653.162.623.133.513.32.343.742.162.451.43
EBITDA 308357.9219.6278.6298.7343.4315.2247.3255.9262.1238.3207.6156.914177.565169.687156.414136.839149.544160.123147.99115.906165.678106.145102.82167.983
EBITDA Ratio 0.1710.1790.1340.1720.1810.1680.1690.1670.1730.1670.180.1830.1850.1920.1990.1910.1790.1820.1950.1920.180.2080.1680.1790.176